Immunohistochemical findings have since facilitated definitive diagnosis; SCL consistently expresses CD34, while S100, expressed in liposarcomas, is negative in SCL [15,16]. In the present case, the lesion was confirmed as SCL based on CD34 positivity and S100 negativity (Figure 3). The gene discussed is CD34; the disease is liposarcoma.